Erratum to Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors (Am J Physiol Gastrointest Liver Physiol (2011), 301, (G634-G643)), 10.1152/ajpgi.00206.2011;Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 301, Issue 4, 2011, Pages

  Renzi, Anastasia ^a,c   Glaser, Shannon ^a,b   DeMorrow, Sharon ^a,b   Mancinelli, Romina ^c   Meng, Fanyin ^a,b   Franchitto, Antonio ^c   Venter, Julie ^a   White, Mellanie ^a   Francis, Heather ^a,b   Han, Yuyan ^a   Alvaro, Domenico ^c   Gaudio, Eugenio ^c   Carpino, Guido ^d   Ueno, Yoshiyuki ^e   Onori, Paolo ^f   Alpini, Gianfranco ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF ROME FORO ITALICO   (Italy)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

cAMP; Cholestasis; Mitosis; PKA; Secretin

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; CRYPTOCHROME 1; CYCLIC AMP; LUZINDOLE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; PER1 PROTEIN; PROTEIN BMAL1; TRANSCRIPTION FACTOR CLOCK;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; CELL GROWTH; CONTROLLED STUDY; GROWTH REGULATION; HORMONE BLOOD LEVEL; IN VIVO STUDY; LIVER HYPERPLASIA; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT;

EID: 80053197271     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.zh3-6008-corr.2011     Document Type: Erratum

References (66)

1. Akbulut KG, Gonul B, Akbulut H. The role of melatonin on gastric mucosal cell proliferation and telomerase activity in ageing. J Pineal Res 47: 308-312, 2009.
2. Alpini G, Glaser S, Robertson W, Rodgers RE, Phinizy JL, Lasater J, LeSage G. Large but not small intrahepatic bile ducts are involved in secretin-regulated ductal bile secretion. Am J Physiol Gastrointest Liver Physiol 272: G1064-G1074, 1997.
3. Alpini G, Glaser S, Ueno Y, Pham L, Podila PV, Caligiuri A, LeSage G, LaRusso NF. Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. Am J Physiol Gastrointest Liver Physiol 274: G767-G775, 1998.
4. Alpini G, Lenzi R, Sarkozi L, Tavoloni N. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. J Clin Invest 81: 569-578, 1988.
5. Alpini G, Prall RT, LaRusso NF. The pathobiology of biliary epithelia. In: The Liver: Biology & Pathobiology, edited by Arias IM, Boyer JL, Chisari FV, Fausto N, Jakoby W, Schachter D, and Shafritz DA. Philadelphia, PA: Lippincott Williams & Wilkins, 2001, p. 421-435.
6. Alpini G, Roberts S, Kuntz SM, Ueno Y, Gubba S, Podila PV, LeSage G, LaRusso NF. Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 110: 1636- 1643, 1996.
7. Alpini G, Ulrich C, Roberts S, Phillips JO, Ueno Y, Podila PV, Colegio O, LeSage G, Miller LJ, LaRusso NF. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol Gastrointest Liver Physiol 272: G289-G297, 1997.
8. Alpini G, Ulrich CD, 2nd Phillips JO, Pham LD, Miller LJ, LaRusso NF. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol Gastrointest Liver Physiol 266: G922-G928, 1994.
9. Alvaro D, Mancino MG, Glaser S, Gaudio E, Marzioni M, Francis H, Alpini G. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 132: 415-431, 2007.
10. Anisimov VN, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Manton KG, Semenchenko AV, Yashin AI. The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int J Cancer 103: 300-305, 2003.
11. Aust S, Thalhammer T, Humpeler S, Jager W, Klimpfinger M, Tucek G, Obrist P, Marktl W, Penner E, Ekmekcioglu C. The melatonin receptor subtype MT1 is expressed in human gallbladder epithelia. J Pineal Res 36: 43-48, 2004.
12. Brzezinski A. Melatonin in humans. N Engl J Med 336: 186-195, 1997.
13. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 47: 2336-2348, 2002.
14. Celinski K, Konturek PC, Slomka M, Cichoz-Lach H, Gonciarz M, Bielanski W, Reiter RJ, Konturek SJ. Altered basal and postprandial plasma melatonin, gastrin, ghrelin, leptin and insulin in patients with liver cirrhosis and portal hypertension without and with oral administration of melatonin or tryptophan. J Pineal Res 46: 408-414, 2009.
15. Cordoba J, Steindl P, Blei AT. Melatonin arrhythmia is corrected after liver transplantation. Am J Gastroenterol 104: 1862-1863, 2009.
16. Cruz A, Padillo FJ, Torres E, Navarrete CM, Munoz-Castaneda JR, Caballero FJ, Briceno J, Marchal T, Tunez I, Montilla P, Pera C, Muntane J. Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. J Pineal Res 39: 143-150, 2005.
17. Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci USA 91: 1824-1828, 1994.
18. Drazen DL, Bilu D, Bilbo SD, Nelson RJ. Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist. Am J Physiol Regul Integr Comp Physiol 280: R1476-R1482, 2001.
19. Esrefoglu M, Gul M, Emre MH, Polat A, Selimoglu MA. Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats. World J Gastroenterol 11: 1951-1956, 2005.
20. Francis H, Franchitto A, Ueno Y, Glaser S, DeMorrow S, Venter J, Gaudio E, Alvaro D, Fava G, Marzioni M, Vaculin B, Alpini G. H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Lab Invest 87: 473-487, 2007.
21. Francis H, Glaser S, DeMorrow S, Gaudio E, Ueno Y, Venter J, Dostal D, Onori P, Franchitto A, Marzioni M, Vaculin S, Vaculin B, Katki K, Stutes M, Savage J, Alpini G. Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/ CaMK I/CREB pathway. Am J Physiol Cell Physiol 295: C499-C513, 2008.
22. Francis H, Glaser S, Ueno Y, LeSage G, Marucci L, Benedetti A, Taffetani S, Marzioni M, Alvaro D, Venter J, Reichenbach R, Fava G, Phinizy JL, Alpini G. cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J Hepatol 41: 528-537, 2004.
23. Glaser S, Gaudio E, Rao A, Pierce LM, Onori P, Franchitto A, Francis HL, Dostal DE, Venter JK, DeMorrow S, Mancinelli R, Carpino G, Alvaro D, Kopriva SE, Savage JM, Alpini G. Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium. Lab Invest 89: 456-469, 2009.
24. Glaser S, Lam IP, Franchitto A, Gaudio E, Onori P, Chow BK, Wise C, Kopriva S, Venter J, White M, Ueno Y, Dostal D, Carpino G, Mancinelli R, Butler W, Chiasson V, DeMorrow S, Francis H, Alpini G. Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation. Hepatology 52: 204-214, 2010.
25. Grechez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem 283: 4535-4542, 2008.
26. Hardeland R. Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites. Cell Mol Life Sci 65: 2001-2018, 2008.
27. Hill SM, Frasch T, Xiang S, Yuan L, Duplessis T, Mao L. Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther 8: 337- 346, 2009.
28. Hong RT, Xu JM, Mei Q. Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol 15: 1452-1458, 2009.
29. Hu S, Yin S, Jiang X, Huang D, Shen G. Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis. Eur J Pharmacol 616: 287-292, 2009.
30. Huang LT, Tiao MM, Tain YL, Chen CC, Hsieh CS. Melatonin ameliorates bile duct ligation-induced systemic oxidative stress and spatial memory deficits in developing rats. Pediatr Res 65: 176-180, 2009.
31. Ishii M, Vroman B, LaRusso NF. Isolation and morphologic characterization of bile duct epithelial cells from normal rat liver. Gastroenterology 97: 1236-1247, 1989.
32. Iuvone PM, Tosini G, Pozdeyev N, Haque R, Klein DC, Chaurasia SS. Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina. Prog Retin Eye Res 24: 433-456, 2005.
33. Jung-Hynes B, Huang W, Reiter RJ, Ahmad N. Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells. J Pineal Res 49: 60-68, 2010.
34. Kato A, Gores GJ, LaRusso NF. Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism. J Biol Chem 267: 15523-15529, 1992.
35. Kirimlioglu H, Ecevit A, Yilmaz S, Kirimlioglu V, Karabulut AB. Effect of resveratrol and melatonin on oxidative stress enzymes, regeneration, and hepatocyte ultrastructure in rats subjected to 70% partial hepatectomy. Transplant Proc 40: 285-289, 2008.
36. Kokkola T, Vaittinen M, Laitinen JT. Inverse agonist exposure enhances ligand binding and G protein activation of the human MT1 melatonin receptor, but leads to receptor down-regulation. J Pineal Res 43: 255-262, 2007.
37. Konturek SJ, Konturek PC, Brzozowska I, Pawlik M, Sliwowski Z, Czesnikiewicz-Guzik M, Kwiecien S, Brzozowski T, Bubenik GA, Pawlik WW. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol 58: 381-405, 2007.
38. Lee S, Donehower LA, Herron AJ, Moore DD, Fu L. Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLos One 5: e10995, 2010.
39. 2+)- and PKC-dependent stimulation of cAMP. Hepatology 40: 1116-1127, 2004.
40. LeSage G, Glaser S, Marucci L, Benedetti A, Phinizy JL, Rodgers R, Caligiuri A, Papa E, Tretjak Z, Jezequel AM, Holcomb LA, Alpini G. Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver. Am J Physiol Gastrointest Liver Physiol 276: G1289-G1301, 1999.
41. Mancinelli R, Franchitto A, Gaudio E, Onori P, Glaser S, Francis H, Venter J, DeMorrow S, Carpino G, Kopriva S, White M, Fava G, Alvaro D, Alpini G. After damage of large bile ducts by gammaaminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes. Am J Pathol 176: 1790-1800, 2010.
42. Mancinelli R, Onori P, Gaudio E, DeMorrow S, Franchitto A, Francis H, Glaser S, Carpino G, Venter J, Alvaro D, Kopriva S, White M, Kossie A, Savage J, Alpini G. Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1. Am J Physiol Gastrointest Liver Physiol 297: G11-G26, 2009.
43. Mao L, Yuan L, Slakey LM, Jones FE, Burow ME, Hill SM. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway (Abstract). Breast Cancer Res 12: R107, 2010.
44. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 302: 255-259, 2003.
45. Naji L, Carrillo-Vico A, Guerrero JM, Calvo JR. Expression of membrane and nuclear melatonin receptors in mouse peripheral organs. Life Sci 74: 2227-2236, 2004.
46. Nakahara K, Murakami N, Nasu T, Kuroda H, Murakami T. Individual pineal cells in chick possess photoreceptive, circadian clock and melatonin-synthesizing capacities in vitro. Brain Res 774: 242-245, 1997.
47. Norris KA, Atkinson AR, Smith WG. TBA (Abstract). Clin Chem 21: 1093, 1975.
48. Ohta Y, Kongo M, Kishikawa T. Melatonin exerts a therapeutic effect on cholestatic liver injury in rats with bile duct ligation. J Pineal Res 34: 119-126, 2003.
49. Onori P, Wise C, Gaudio E, Franchitto A, Francis H, Carpino G, Lee V, Lam I, Miller T, Dostal DE, Glaser S. Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor. Int J Cancer 127: 43-54, 2010.
50. Peschke E, Muhlbauer E, Musshoff U, Csernus VJ, Chankiewitz E, Peschke D. Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res 33: 63-71, 2002.
51. Poon AM, Choy EH, Pang SF. Modulation of blood glucose by melatonin: a direct action on melatonin receptors in mouse hepatocytes. Biol Signals Recept 10: 367-379, 2001.
52. Porkka-Heiskanen T, Laakso ML, Stenberg D, Alila A, Johansson G. Increase in testosterone sensitivity induced by constant light in relation to melatonin injections in rats. J Reprod Fertil 96: 331-336, 1992.
53. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 12: 151-180, 1991.
54. Reiter RJ, Tan DX, Korkmaz A. The circadian melatonin rhythm and its modulation: possible impact on hypertension. J Hypertens Suppl 27: S17-S20, 2009.
55. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 92: 8734-8738, 1995.
56. Rowe SA, Kennaway DJ. Melatonin in rat milk and the likelihood of its role in postnatal maternal entrainment of rhythms. Am J Physiol Regul Integr Comp Physiol 282: R797-R804, 2002.
57. Rowland NE, Bellush LL, Fregly MJ. Nycthemeral rhythms and sodium chloride appetite in rats. Am J Physiol Regul Integr Comp Physiol 249: R375-R378, 1985.
58. Rutenburg AM, Kim H, Fischbein JW, Hanker JS, Wasserkrug HL, Seligman AM. Histochemical and ultrastructural demonstration of gamma- glutamyl transpeptidase activity. J Histochem Cytochem 17: 517-526, 1969.
59. Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nat Rev Cancer 9: 886-896, 2009.
60. Sezer A, Hatipoglu AR, Usta U, Altun G, Sut N. Effects of intraperitoneal melatonin on caustic sclerosing cholangitis due to scolicidal solution in a rat model. Curr Ther Res 71: 118-128, 2010.
61. Shiu SY, Pang B, Tam CW, Yao KM. Signal transduction of receptormediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of Galpha and Galpha proteins. J Pineal Res 49: 301-311, 2010.
62. Tahan G, Akin H, Aydogan F, Ramadan SS, Yapicier O, Tarcin O, Uzun H, Tahan V, Zengin K. Melatonin ameliorates liver fibrosis induced by bile-duct ligation in rats. Can J Surg 53: 313-318, 2010.
63. Ueno Y, Alpini G, Yahagi K, Kanno N, Moritoki Y, Fukushima K, Glaser S, LeSage G, Shimosegawa T. Evaluation of differential gene expression by microarray analysis in small and large cholangiocytes isolated from normal mice. Liver Int 23: 449-459, 2003.
64. Velissaris D, Karanikolas M, Kalogeropoulos A, Solomou E, Polychronopoulos P, Thomopoulos K, Labropoulou-Karatza C. Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy. World J Gastroenterol 14: 4190-4195, 2008.
65. Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ, Wurtman RJ. Bioavailability of oral melatonin in humans. Neuroendocrinology 39: 307-313, 1984.
66. Yie SM, Johansson E, Brown GM. Competitive solid-phase enzyme immunoassay for melatonin in human and rat serum and rat pineal gland. Clin Chem 39: 2322-2325, 1993.